Evaluation of Effectiveness of Oral and Vaginal Misoprostol Administration for Cervical Ripening in Women Before Operative Hysteroscopy

Phase 3

• Conditions: Cervical Ripening.; Abnormal uterine and vaginal bleeding, unspecified; N93.9

• Registration Number: IRCT20220102053602N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

Based on the indications for hysteroscopy

Exclusion Criteria

Contraindications for anti-prostaglandin drugs (asthma, or glaucoma)
Women who are contraindicated for hysteroscopy (pregnancy, inflammatory bowel disease, malignancy)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cervical Ripening. Timepoint: 12 Hours. Method of measurement: Hegar dilator.